Knockdown of galectin-3 in lung adenocarcinomas decreased stemness-related genes like Oct4, Sox2, Nanog, and CD133, as well as the capability of tumor initiation in vitro and in vivo. The gene discussed is SOX2; the disease is neoplasm.